Viridian Therapeutics, Inc.\DE (VRDN) Prepaid Assets (2013 - 2026)
Viridian Therapeutics, Inc.\DE's (VRDN) quarterly Prepaid Assets came in at $22.6 million in Q1 2026, up 9.5% year-on-year from $20.6 million in Q1 2025, and up 15.23% quarter-over-quarter from $19.6 million in Q4 2025.
Viridian Therapeutics, Inc.\DE (VRDN) Prepaid Assets (2013 - 2026) Analysis & Trends
Viridian Therapeutics, Inc.\DE's Prepaid Assets history runs 14 years deep, the most recent figure standing at $22.6 million for Q1 2026.
- On a quarterly basis, Prepaid Assets rose 9.5% year-over-year to $22.6 million in Q1 2026; TTM through Mar 2026 was $22.6 million, a 9.5% increase from a year earlier, with the FY2025 full-year figure at $19.6 million, down 6.21% from the prior year.
- Prepaid Assets grew to $22.6 million in Q1 2026 per VRDN's latest filing, from $19.6 million in the prior quarter.
- Across five years, Prepaid Assets topped out at $22.6 million in Q1 2026 and bottomed at $3.4 million in Q1 2022.
- The 5-year median for Prepaid Assets is $11.0 million (2025), against an average of $12.2 million.
- Across the five-year window, Prepaid Assets soared 180.83% in 2023 and slipped 21.92% in 2025, its largest moves.
- Year by year, Prepaid Assets stood at $6.5 million in 2022, then jumped by 38.11% to $9.0 million in 2023, then soared by 131.81% to $20.9 million in 2024, then fell by 6.21% to $19.6 million in 2025, then increased by 15.23% to $22.6 million in 2026.
- Per Business Quant, the three latest VRDN Prepaid Assets figures stand at $22.6 million (Q1 2026), $19.6 million (Q4 2025), and $11.0 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Viridian Therapeutics, Inc.\DE | 229.55 Mn | 229.55 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 22.56 Mn |
| Dec 31, 2025 | 19.58 Mn |
| Sep 30, 2025 | 11.01 Mn |
| Jun 30, 2025 | 15.39 Mn |
| Mar 31, 2025 | 20.61 Mn |
| Dec 31, 2024 | 20.88 Mn |
| Sep 30, 2024 | 14.10 Mn |
| Jun 30, 2024 | 10.30 Mn |
| Mar 31, 2024 | 13.53 Mn |
| Dec 31, 2023 | 9.01 Mn |
| Sep 30, 2023 | 10.73 Mn |
| Jun 30, 2023 | 11.94 Mn |
| Mar 31, 2023 | 8.62 Mn |
| Dec 31, 2022 | 6.52 Mn |
| Sep 30, 2022 | 5.64 Mn |
| Jun 30, 2022 | 4.25 Mn |
| Mar 31, 2022 | 3.44 Mn |
| Dec 31, 2021 | 2.75 Mn |
| Sep 30, 2021 | 3.65 Mn |
| Jun 30, 2021 | 4.11 Mn |